Literature DB >> 19730981

Association between depressive symptoms and reproductive variables in a group of perimenopausal women attending a menopause clinic in México City.

Mónica Flores-Ramos1, Gerhard Heinze, Roberto Silvestri-Tomassoni.   

Abstract

The aim of this study was to explore the association between depressive symptoms and some variables related to the reproductive life, such as history of premenstrual dysphoric disorder, antecedent of postpartum depression, previous use of hormonal contraceptives, and current hot flushes, in a group of perimenopausal women attending a menopause clinic. Perimenopausal women, 45 to 55 years old, who had not received hormonal replacement therapy and/or psychotropic medication, were invited to participate in this study. 141 perimenopausal women were included; we obtained their psychiatric and gynecological data, and we evaluated their depressive symptomatology using the CES-D scale. There were a significantly higher number of cases of previous depressive episodes, PMDD and PPD history in depressed patients compared with non-depressed women; current hot flushes prevalence was similar between depressed and non-depressed women. Patients with a PMDD history were more likely to have experienced previous depressive episodes, a PPD history and high levels of depression. Variables associated with the level of depression were a previous history of PMDD, current hot flushes, and previous depressive episodes. The occurrence of perimenopausal depression is related to a previous history of PMDD, PPD, and depressive episodes; hot flushes only increase the severity of the depressive episode.

Entities:  

Mesh:

Year:  2010        PMID: 19730981     DOI: 10.1007/s00737-009-0107-0

Source DB:  PubMed          Journal:  Arch Womens Ment Health        ISSN: 1434-1816            Impact factor:   3.633


  1 in total

1.  Negative affect symptoms, anxiety sensitivity, and vasomotor symptoms during perimenopause.

Authors:  Marianna de B Jaeger; Camila S Miná; Sofia Alves; Gabriela J Schuh; Maria C Wender; Gisele G Manfro
Journal:  Braz J Psychiatry       Date:  2020-10-09       Impact factor: 2.697

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.